# A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab

> **NCT00887965** · PHASE2 · COMPLETED · sponsor: **Amgen** · enrollment: 15 (actual)

## Conditions studied

- Low Bone Mass
- Low Bone Mineral Density
- Osteoporosis
- Postmenopausal Osteoporosis

## Interventions

- **DRUG:** Previous denosumab

## Key facts

- **NCT ID:** NCT00887965
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2010-06
- **Final completion:** 2010-08
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2013-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00887965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00887965, "A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00887965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*